(Q46721562)
Statements
1 reference
Minimal residual disease in patients with chronic myelogenous leukemia undergoing long-term treatment with recombinant interferon alpha-2b alone or in combination with interferon gamma (English)
1 reference
B Opalka
1 reference
U B Wandl
1 reference
R Becher
1 reference
O Kloke
1 reference
M Nagel-Hiemke
1 reference
T Moritz
1 reference
U Beer
1 reference
S Seeber
1 reference
N Niederle
1 reference
1 November 1991
1 reference
1 reference
78
1 reference
9
1 reference
2188-2193
1 reference